Abiopharma

🔍 Noblet Natalia (Director)

Company: STONERIDGE INC (SRI)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Shares, without par value at $7.31 per share (Direct)
  Date: 2026-08-10 | Code: P | equity_swap_involved: 0 | shares_owned_after: 5,000.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 61,863 shares of Share Units (Derivative)
  Date: 2026-08-10 | Code: H | shares_owned_after: 61,863.00 | Footnotes: F2, F2, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The 5,000 Common Share were purchased in multiple transactions at prices ranging from $7.28 to $7.32 per share, all executed on August 10, 2026. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
• F2: Share Units granted to the Reporting Person pursuant to the Company's Long-Term Incentive Plan, are payable on a one-for-one basis in Company common shares: 27, 279 of which vest ratably in equal annual installments of one-third (1/3) on each of March 16, 2027, March 16, 2028, and March 16, 2029; 22,320 of which vest on March 1, 2028; and 12, 264 of which vest on September 9, 2026. All vesting are subject to the Reporting Person's continued employment on each applicable vesting date.